Molnupiravir has received minimal to no coverage my the lamestream outlets. Hmm. My question is if the stage 3 trials of molnupiravir show the efficacy of stage 2 when will the FDA give the anti-viral drug an EUA and how they will authorize its use? If in fact we are headed towards herd immunity why not mass produce this drug and ensure on hand availability for everyone so if they become symptomatic with cv19 symptoms or test positive they can start the medication then? Many healthcare facilities provide the drug tamiflu (even though its shown minimal efficacy in reducing influenza A symptoms) free of charge to staff if there is an influenza outbreak at the facility. Unfortunately given the billions of dollars spent on vaccine R&D and the amount of money to be made on vaccines the use of this drug will probably be limited to those hospitalized or high risk groups.That said, the end of face diapers and other restrictions is hopefully in sight.